{"id":"https://openalex.org/W4313354518","doi":"https://doi.org/10.4049/jimmunol.192.supp.137.2","title":"PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3 (THER4P.890)","display_name":"PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3 (THER4P.890)","publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W4313354518","doi":"https://doi.org/10.4049/jimmunol.192.supp.137.2"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.192.supp.137.2","doi":"https://doi.org/10.4049/jimmunol.192.supp.137.2","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.192.supp.137.2","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114139871","display_name":"Xinming Cai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinming Cai","raw_affiliation_strings":["Novartis Institutes for Biomedical Research , Cambridge, MA","1Novartis Institutes for Biomedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research , Cambridge, MA","institution_ids":[]},{"raw_affiliation_string":"1Novartis Institutes for Biomedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102086971","display_name":"YongYao Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongyao Xu","raw_affiliation_strings":["Novartis Institutes for Biomedical Research , Cambridge, MA","1Novartis Institutes for Biomedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research , Cambridge, MA","institution_ids":[]},{"raw_affiliation_string":"1Novartis Institutes for Biomedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036811221","display_name":"You\u2010Me Kim","orcid":"https://orcid.org/0000-0001-8780-704X","observed_orcids":["https://orcid.org/0000-0001-8780-704X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"You-Me Kim","raw_affiliation_strings":["Novartis Institutes for Biomedical Research , Cambridge, MA","1Novartis Institutes for Biomedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research , Cambridge, MA","institution_ids":[]},{"raw_affiliation_string":"1Novartis Institutes for Biomedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027891362","display_name":"Joseph Loureiro","orcid":"https://orcid.org/0000-0001-7222-9160","observed_orcids":["https://orcid.org/0000-0001-7222-9160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Loureiro","raw_affiliation_strings":["Novartis Institutes for Biomedical Research , Cambridge, MA","1Novartis Institutes for Biomedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research , Cambridge, MA","institution_ids":[]},{"raw_affiliation_string":"1Novartis Institutes for Biomedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102002971","display_name":"Qian Huang","orcid":"https://orcid.org/0000-0002-4202-8664","observed_orcids":["https://orcid.org/0000-0002-4202-8664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Huang","raw_affiliation_strings":["Novartis Institutes for Biomedical Research , Cambridge, MA","1Novartis Institutes for Biomedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research , Cambridge, MA","institution_ids":[]},{"raw_affiliation_string":"1Novartis Institutes for Biomedical Research, Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"192","issue":"Supplement_1","first_page":"137.2","last_page":"137.2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.43459999561309814,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pikfyve","display_name":"PIKfyve","score":1.0},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.9779999852180481},{"id":"https://openalex.org/keywords/toll-like-receptor-signaling","display_name":"Toll-like receptor signaling","score":0.9440000057220459},{"id":"https://openalex.org/keywords/atf3","display_name":"ATF3","score":0.9819999933242798},{"id":"https://openalex.org/keywords/phosphatidylinositol-3-phosphate","display_name":"phosphatidylinositol 3-phosphate","score":0.8629999756813049},{"id":"https://openalex.org/keywords/endolysosomal-trafficking","display_name":"endolysosomal trafficking","score":0.9470000267028809},{"id":"https://openalex.org/keywords/transcriptional-repression","display_name":"transcriptional repression","score":0.8379999995231628},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9290000200271606},{"id":"https://openalex.org/keywords/phosphoinositide-signaling","display_name":"phosphoinositide signaling","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6652799844741821},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.5501781105995178},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5241211652755737},{"id":"https://openalex.org/C2780610907","wikidata":"https://www.wikidata.org/wiki/Q2273248","display_name":"Phosphatidylinositol","level":3,"score":0.5061821341514587},{"id":"https://openalex.org/C158448853","wikidata":"https://www.wikidata.org/wiki/Q425218","display_name":"Repressor","level":4,"score":0.47079673409461975},{"id":"https://openalex.org/C157880135","wikidata":"https://www.wikidata.org/wiki/Q17832633","display_name":"ATF3","level":5,"score":0.4626520574092865},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.41718801856040955},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.20778021216392517},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19076332449913025},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.18806713819503784},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10922864079475403}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.192.supp.137.2","doi":"https://doi.org/10.4049/jimmunol.192.supp.137.2","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.192.supp.137.2","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2131297695","https://openalex.org/W2146960589","https://openalex.org/W1988252579","https://openalex.org/W2161511682","https://openalex.org/W1154551479","https://openalex.org/W2037127114","https://openalex.org/W2161791643","https://openalex.org/W1995355664","https://openalex.org/W2063595818","https://openalex.org/W2055702238"],"abstract_inverted_index":{"Abstract":[0],"Type":[1,19],"I":[2,20,54,82,118,145],"IFN":[3,21,55,83,119],"plays":[4,71],"a":[5,41,72,134],"key":[6],"role":[7,74],"in":[8,56,75,93],"anti-viral":[9],"responses.":[10],"It":[11],"also":[12],"has":[13],"been":[14],"shown":[15],"that":[16,139],"deregulation":[17],"of":[18,26,31,52,88,100,105,116,143],"expression":[22,51,104,120],"following":[23],"abnormal":[24],"activation":[25],"TLRs":[27],"contributes":[28],"to":[29,63,123],"pathogenesis":[30],"systemic":[32],"lupus":[33],"erythematosus.":[34],"In":[35],"this":[36],"study":[37],"we":[38,131],"find":[39],"PIKfyve,":[40],"class":[42],"III":[43],"lipid":[44],"kinase,":[45],"is":[46,110],"required":[47],"for":[48,114,153],"endolysosomal":[49,76],"TLR-induced":[50],"type":[53,81,117,144],"mouse":[57],"and":[58,66,70,90,112,126],"human":[59],"cells.":[60],"PIKfyve":[61,79,101,154],"binds":[62],"phosphatidylinositol":[64,68],"3P":[65],"synthesizes":[67],"(3,5)P2,":[69],"critical":[73],"trafficking.":[77],"However,":[78],"modulates":[80],"production":[84],"via":[85],"mechanisms":[86],"independent":[87],"receptor":[89],"ligand":[91],"trafficking":[92],"endolysosomes.":[94],"Instead,":[95],"pharmacological":[96],"or":[97],"genetic":[98],"inactivation":[99],"rapidly":[102],"induces":[103],"transcription":[106],"repressor":[107],"ATF3,":[108],"which":[109,147],"necessary":[111],"sufficient":[113],"suppression":[115],"by":[121],"binding":[122],"its":[124,128],"promoter":[125],"blocking":[127],"transcription.":[129],"Thus,":[130],"have":[132],"uncovered":[133],"novel":[135],"phosphoinositide-mediated":[136],"regulatory":[137],"mechanism":[138],"controls":[140],"TLR-mediated":[141],"induction":[142],"IFN,":[146],"may":[148],"provide":[149],"new":[150],"therapeutic":[151],"indication":[152],"inhibitor.":[155]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-01-06T00:00:00"}